Risks and Benefits of Pharmacological Prophylaxis for Venous Thromboembolism Prevention in Patients Undergoing Robotic Partial Nephrectomy.

Journal: The Journal of urology

Published Date: May 1, 2016

Abstract

PURPOSE: We investigate the safety and efficacy of pharmacological venous thromboembolism prophylaxis in patients treated with robotic partial nephrectomy at our center.

Authors

Onder Kara

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Homayoun Zargar
Oktay Akca
Hiury S Andrade

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Peter Caputo

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Matthew J Maurice

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Daniel Ramirez

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Robert J Stein

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Jihad H Kaouk

Keywords

Anticoagulants Female Follow-Up Studies Humans Incidence Male Middle Aged Nephrectomy Ohio Operative Time Postoperative Complications Retrospective Studies Risk Assessment Robotics Treatment Outcome Venous Thromboembolism

External Resources

View on PubMed Access via DOI PubMed (26626222)

Risks and Benefits of Pharmacological Prophylaxis for Venous Thromboembolism Prevention in Patients Undergoing Robotic Partial Nephrectomy.

Abstract

Authors

Keywords

External Resources

Popular Topics

Recent Journals